Capricor Therapeutics reported earnings of -$ 0.73 per CAPR share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.44 |
| Earnings Per Share (Surprise) | -$ 0.73 (-$ 0.29) |
| Last Year's EPS | -$ 0.57 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Capricor Therapeutics beat analysts’ expectations 29 times and fell short of expectations 32 time(s). Capricor Therapeutics reported earnings per share of -$ 0.73 in the last report falling to reach an estimated EPS of -$ 0.44 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.44 | -$ 0.73 | -$ 0.54 | |
| Aug 14, 2026 | -$ 0.59 | -$ 0.70 | -$ 0.57 | |
| May 12, 2026 | -$ 0.55 | -$ 0.59 | -$ 0.53 | |
| Mar 12, 2026 | -$ 0.51 | -$ 0.62 | -$ 0.16 | |
| Nov 10, 2025 | -$ 0.54 | -$ 0.54 | -$ 0.38 | |
| Aug 11, 2025 | -$ 0.48 | -$ 0.57 | -$ 0.35 | |
| May 13, 2025 | -$ 0.33 | -$ 0.53 | -$ 0.31 | |
| Mar 19, 2025 | -$ 0.31 | -$ 0.16 | -$ 0.02 | |
| Nov 13, 2024 | -$ 0.36 | -$ 0.38 | -$ 0.25 | |
| Aug 7, 2024 | -$ 0.36 | -$ 0.35 | -$ 0.29 | |
| May 13, 2024 | -$ 0.11 | -$ 0.31 | -$ 0.31 | |
| Feb 29, 2024 | -$ 0.09 | -$ 0.02 | -$ 0.31 | |
| Nov 14, 2023 | -$ 0.29 | -$ 0.25 | -$ 0.26 | |
| Aug 7, 2023 | -$ 0.35 | -$ 0.29 | -$ 0.29 | |
| May 11, 2023 | -$ 0.32 | -$ 0.31 | -$ 0.32 | |
| Mar 15, 2023 | -$ 0.33 | -$ 0.31 | -$ 0.26 | |
| Nov 10, 2022 | -$ 0.29 | -$ 0.26 | -$ 0.17 | |
| Aug 10, 2022 | -$ 0.25 | -$ 0.29 | -$ 0.21 | |
| May 10, 2022 | - | -$ 0.32 | -$ 0.23 | |
| Mar 10, 2022 | -$ 0.19 | -$ 0.26 | -$ 0.21 |
Capricor Therapeutics’s stock was trading at $ 9.85 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, CAPR’s price increased to $ 11.22 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.73 | $ 9.85 | $ 11.22 | |
| Aug 14, 2026 | -$ 0.70 | $ 4.21 | $ 7.45 | |
| May 12, 2026 | -$ 0.59 | $ 31.90 | $ 30.33 | |
| Mar 12, 2026 | -$ 0.62 | $ 33.57 | $ 30.50 | |
| Nov 10, 2025 | -$ 0.54 | $ 5.93 | $ 6.20 | |
| Aug 11, 2025 | -$ 0.57 | $ 9.07 | $ 8.04 | |
| May 13, 2025 | -$ 0.53 | $ 7.11 | $ 7.67 | |
| Mar 19, 2025 | -$ 0.16 | $ 11.61 | $ 14.36 | |
| Nov 13, 2024 | -$ 0.38 | $ 18.10 | $ 18.49 | |
| Aug 7, 2024 | -$ 0.35 | $ 3.91 | $ 3.88 | |
| May 13, 2024 | -$ 0.31 | $ 5.30 | $ 5.20 | |
| Feb 29, 2024 | -$ 0.02 | $ 4.33 | $ 4.57 | |
| Nov 14, 2023 | -$ 0.25 | $ 2.84 | $ 3.21 | |
| Aug 7, 2023 | -$ 0.29 | $ 4.57 | $ 5.73 | |
| May 11, 2023 | -$ 0.31 | $ 4.08 | $ 4.03 | |
| Mar 15, 2023 | -$ 0.31 | $ 4.64 | $ 4.56 | |
| Nov 10, 2022 | -$ 0.26 | $ 4.71 | $ 4.55 | |
| Aug 10, 2022 | -$ 0.29 | $ 4.61 | $ 5.28 | |
| May 10, 2022 | -$ 0.32 | $ 3.12 | $ 2.95 | |
| Mar 10, 2022 | -$ 0.26 | $ 4.55 | $ 4.18 |
Capricor Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Capricor Therapeutics missed analysts’ expectations during the last earnings period by
